Furthermore, stronger cytoplasmic Prx III expression was significantly associated with node-negative status (p = 0.007) and better tumor differentiation (p = 0.033), whereas higher cytoplasmic Prx V expression was significantly associated with smaller tumor size (p = 0.029) and node-negative status (p = 0.003) [34]. The gene discussed is PRDX5; the disease is neoplasm.